Novel 3-(4-piperidinylthio)-1H-indoles as potent nonopioid orally active central analgesics

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 8, 2000, Pages 805-809

  Potin, Dominique ^b   Parnet, Véronique ^a   Teulon, Jean Marie ^a   Camborde, Françoise ^a   Caussade, François ^a   Meignen, Joëlle ^a   Provost, Daniel ^a   Cloarec, Alix ^a  

^a UPSA Laboratories   (France)

^b Chemistry Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 PIPERIDINYLTHIO) 1H INDOLE DERIVATIVE; INDOLE DERIVATIVE; MORPHINE; NALOXONE; PHENYLQUINONE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; SEROTONIN UPTAKE; WRITHING TEST;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANIMALS; INDOLES; MICE;

ANIMALIA;

EID: 0034678641     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00102-5     Document Type: Article

References (23)

1. Hayes S.R., Vogelsang J. J. Post. Anesth. Nurs. 6:1991;125.
2. (a) Vanegas, G.; Ripamonti, C.; Sbanotto, A.; De Conno, F. Cancer Nurs. 1998, 21, 289.
3. (b) Ecoffey, C. Cah. Anesthesiol. 1991, 39, 115.
4. Walsh, T. D. J. Pain Symptom. Manage. 1990, 5, 362.
5. For a recent review of approaches to pain therapy: Williams, M.; Kowaluk, E. A.; Arneric, S. P. J. Med. Chem. 1999, 42, 1481.
6. Serotonin and Pain: Proceedings of the International Symposium on Serotonin and Pain, La Roque-Gageac, 17-21 September 1989;
7. Besson, J.-M., Ed.; Excerpta Medica: Amsterdam, New York, Oxford, 1990; pp 1-339.
8. Hibert M.F., Gittos M.W., Middlemiss D.N., Mir A.K., Fozard J.R. J. Med. Chem. 31:1988;1087.
9. Guillaume J., Dumont C., Laurent J., Nédélec L. Eur. J. Med. Chem. 22:1987;33.
10. Mignani S., Damour D., Doble A., Labaudinière R., Malleron J.L., Piot O., Gueremy C. Bioorg. Med. Chem. Lett. 3:1993;1913.
11. Bomhof M., Enahoro H., Winter P., Hassani H. Cephalalgia. 17:1997;424.
12. Perregaard J., Arnt J., Bøgesø K.P., Hyttel J., Sánchez C. J. Med. Chem. 35:1992;1092.
13. Major R.T., Dürsch F. J. Org. Chem. 26:1961;1867.
14. Barrera H., Lyle R.E. J. Org. Chem. 27:1962;641.
15. Engel J., Bork A., Nubert I., Schönenberger H. Arch. Pharm. (Weinheim). 321:1988;821.
16. It is not necessary to protect the piperidine nitrogen atom from oxydation since this amine is protonated under the reaction conditions (pH around 4-5).
17. Siegmund E., Cadmus R., Lu G.A. Proc. Soc. Exp. Biol. Med. 95:1957;729.
18. Eddy N.B., Toucheberry C.F., Lieberman J.E. J. Pharmacol. Exp. Ther. 98:1950;121.
19. In tolerance studies 1i exhibited serotonin-related side effects (flat body posture, tremors, forepaw treadings) at doses approximately 25 times the active dose in both mice and rats.
20. Hertz, F.; Ranson, M.; Lwoff, J. M. Arzneim. Forsch. 1980, 30, 1549.
21. Haffner F. Dtsch. Med. Wochenschr. 55:1929;731.
22. Pearson C.M., Wood F.D. Arthritis Rheum. 2:1959;440.
23. 4 (guinea pig)].